Guruprasadh B , MD - Founder and Chief Scientific Officer
Guruprasadh is a physician-scientist with over 15 years of experience leading clinical development and medical affairs programs in ophthalmology. He has held leadership roles at industry pioneers, including Novartis, Regeneron, and Allergan, where he helped advance next-generation retinal therapeutics in nAMD, DME, RVO, and Uveitis.
Dirk Sauer, PhD - Chief Development Advisor
With over 35 years of leadership in drug development, including more than 20 years dedicated to ophthalmology and retina therapeutics, Dirk brings a wealth of expertise that will be instrumental in guiding our journey. His strategic insight and deep domain knowledge will play a pivotal role in shaping NeuParadigmBio’s evolution into a successful drug discovery and development company
Mark S. Wuttke, PhD - Chief Strategy Advisor
Mark brings over 20 years of global leadership in pharmaceutical and medical device development, with deep expertise in retina and ophthalmology therapies. He has held senior roles across industry, including CEO of Dopavision GmbH and Global Program Head at Novartis, where he led the development of pioneering treatments in nAMD, myopia, amblyopia, and presbyopia.
Mark’s extensive experience in strategic planning will be instrumental in shaping our vision and accelerating our success as a drug discovery and development company.
Viral Kansara , PhD - Chief Discovery Advisor
Dr. Kansara brings over 20 years of preclinical & translational expertise in ocular immunology, inflammation, and angiogenesis research, with a proven track record at Clearside, Novartis, and Merck.
At NeuParadigmBio, he will advise us on the discovery strategy and early development, advancing our New Paradigm of biologics.
Alexander Baker, PhD - Chief Translation Advisor
Dr. Baker brings extensive experience in translational medicine, early-stage biotechnology, and asset creation. His expertise spans academia and industry, advancing innovative biologics, including antibodies and gene therapies, from inception through clinical application.